Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Biologics - Large Molecule
Sort By
Newest First
Sign in
1 / 30
1 / 30
Biomanufacturing
Enabling Digital Twins With Computational Fluid Dynamics Modeling
Sangmin Paik, Ph.D.
Samsung Biologics
PAO-01-25-CL-06
Jan 15, 2025
Clinical CRO
HyBryte™ Expanded Treatment Continues to Demonstrate Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma
Soligenix, Inc.
PR-01-25-NI-10
Jan 14, 2025
Antibody
Timberlyne Therapeutics Secures $180M Series A to Advance CM313, a Promising Anti-CD38 Antibody for High-Need Diseases.
Timberlyne Therapeutics
PR-01-25-NI-07
Jan 10, 2025
Agreement
Mediar Therapeutics and Lilly Sign Global Licensing Agreement to Advance WISP1 Antibody to Treat Idiopathic Pulmonary Fibrosis
Mediar Therapeutics
PR-01-25-NI-06
Jan 10, 2025
Large Molecule
Managing Pharmacovigilance Challenges for Biosimilars
Ivana Lisec, MPharm
PrimeVigilance
PAO-11-24-CL-05
Jan 02, 2025
Sustainability
Tackling Plastic Waste: The Elephant in the Room of Pharma’s Sustainability Drive
Sophie Lutter, Ph.D.
Pharma's Almanac
PAO-01-25-CL-1
Jan 02, 2025
CDMO
Navigating the Complexities of Microbial and Mammalian Manufacturing
Peter Boman; Helena Pettersson
NorthX Biologics
PAO-12-24-CL-3
Jan 02, 2025
Autoimmune Diseases
Why Autoimmune Diseases Are Taking Center Stage: Rising Prevalence, Breakthroughs, and Market Opportunities
Chia Chia Sun; Gardiner Smith
Fab Biopharma
PAO-12-24-CL-2
Dec 11, 2024
CDMO
Advancing the Science of Technical and Therapeutic Proteins
Eva-Karin Gidlund, Ph.D.
NorthX Biologics
PAO-11-24-CL-10
Dec 04, 2024
Antibody
Spyre Therapeutics Announces First Participants Dosed in Phase 1 Trials of Novel Half-life Extended Anti-TL1A Antibodies
Spyre Therapeutics, Inc.
PR-12-24-NI-125
Dec 03, 2024
PPQ
Fast Path to Market: Going from GMP1 to PPQ in Just 12 Months
Jessica Feldman, Ph.D.; Henning Gerschewski
Rentschler Biopharma SE
PAO-10-24-CL-12
Dec 02, 2024
Lyophilization
Enhancing Biopharmaceutical Stability Through Lyophilization
David King; Hoju Lee; Sungjin Park; Yeonju Yoon
Samsung Biologics
PAO-11-24-CL-08
Nov 26, 2024
Financing
EQT Life Sciences leads €54 Million Series A Financing of ATB Therapeutics
EQT
PR-11-24-NI-116
Nov 20, 2024
Clinical Trials
Concerto Biosciences Announces First Participant Dosed with Live Biotherapeutic ENS-002 in Phase 1 Trial for Atopic Dermatitis
Concerto Biosciences
PR-11-24-NI-112
Nov 19, 2024
Technology
Building the Future of E. coli Biomanufacturing with Protein Secretion
Trond Erik Vee Aune, Ph.D.; Jostein Malmo, Ph.D.; Dominik Bahiense de Mello
Vectron Biosolutions
PAO-11-24-CL-07
Nov 18, 2024
Biotherapeutics
Building on Australia's Existing Biopharma Infrastructure
BIoCina
PAO-11-24-RTM-07
Nov 15, 2024
ADC
Chime Biologics and Waterstone Jointly Develop and Manufacture Antibody-Drug Conjugate (ADC)
Chime Biologics
PR-10-24-NI-91
Nov 12, 2024
Biomanufacturing
Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing
Ginkgo Bioworks
PR-10-24-NI-92
Nov 12, 2024
Biomanufacturing
Transforming xRNA Manufacturing with Digital Technologies and Continuous Processing
Aaron B. Cowley, Ph.D.
ReciBioPharm
PAO-11-24-CL-04
Nov 11, 2024
Large Molecule
Johnson & Johnson Submits Applications Seeking Approval as Subcutaneous Monotherapy for High-Risk moldering Multiple Myeloma
Johnson & Johnson
PR-10-24-NI-88
Nov 08, 2024
